BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19880070)

  • 1. Of founder populations, long QT syndrome, and destiny.
    Brink PA; Schwartz PJ
    Heart Rhythm; 2009 Nov; 6(11 Suppl):S25-33. PubMed ID: 19880070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome.
    Schwartz PJ; Vanoli E; Crotti L; Spazzolini C; Ferrandi C; Goosen A; Hedley P; Heradien M; Bacchini S; Turco A; La Rovere MT; Bartoli A; George AL; Brink PA
    J Am Coll Cardiol; 2008 Mar; 51(9):920-9. PubMed ID: 18308161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification.
    Crotti L; Spazzolini C; Schwartz PJ; Shimizu W; Denjoy I; Schulze-Bahr E; Zaklyazminskaya EV; Swan H; Ackerman MJ; Moss AJ; Wilde AA; Horie M; Brink PA; Insolia R; De Ferrari GM; Crimi G
    Circulation; 2007 Nov; 116(21):2366-75. PubMed ID: 17984373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population.
    Brink PA; Crotti L; Corfield V; Goosen A; Durrheim G; Hedley P; Heradien M; Geldenhuys G; Vanoli E; Bacchini S; Spazzolini C; Lundquist AL; Roden DM; George AL; Schwartz PJ
    Circulation; 2005 Oct; 112(17):2602-10. PubMed ID: 16246960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex is a moderator of the association between NOS1AP sequence variants and QTc in two long QT syndrome founder populations: a pedigree-based measured genotype association analysis.
    Winbo A; Stattin EL; Westin IM; Norberg A; Persson J; Jensen SM; Rydberg A
    BMC Med Genet; 2017 Jul; 18(1):74. PubMed ID: 28720088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics.
    Piippo K; Swan H; Pasternack M; Chapman H; Paavonen K; Viitasalo M; Toivonen L; Kontula K
    J Am Coll Cardiol; 2001 Feb; 37(2):562-8. PubMed ID: 11216980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCNE1 D85N polymorphism--a sex-specific modifier in type 1 long QT syndrome?
    Lahtinen AM; Marjamaa A; Swan H; Kontula K
    BMC Med Genet; 2011 Jan; 12():11. PubMed ID: 21244686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A challenge for mutation specific risk stratification in long QT syndrome type 1.
    Yagi N; Itoh H; Hisamatsu T; Tomita Y; Kimura H; Fujii Y; Makiyama T; Horie M; Ohno S
    J Cardiol; 2018 Jul; 72(1):56-65. PubMed ID: 29439887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome.
    Duchatelet S; Crotti L; Peat RA; Denjoy I; Itoh H; Berthet M; Ohno S; Fressart V; Monti MC; Crocamo C; Pedrazzini M; Dagradi F; Vicentini A; Klug D; Brink PA; Goosen A; Swan H; Toivonen L; Lahtinen AM; Kontula K; Shimizu W; Horie M; George AL; Trégouët DA; Guicheney P; Schwartz PJ
    Circ Cardiovasc Genet; 2013 Aug; 6(4):354-61. PubMed ID: 23856471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases.
    Winkel BG; Larsen MK; Berge KE; Leren TP; Nissen PH; Olesen MS; Hollegaard MV; Jespersen T; Yuan L; Nielsen N; Haunsø S; Svendsen JH; Wang Y; Kristensen IB; Jensen HK; Tfelt-Hansen J; Banner J
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1092-8. PubMed ID: 22882672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long QT syndrome in adults.
    Sauer AJ; Moss AJ; McNitt S; Peterson DR; Zareba W; Robinson JL; Qi M; Goldenberg I; Hobbs JB; Ackerman MJ; Benhorin J; Hall WJ; Kaufman ES; Locati EH; Napolitano C; Priori SG; Schwartz PJ; Towbin JA; Vincent GM; Zhang L
    J Am Coll Cardiol; 2007 Jan; 49(3):329-37. PubMed ID: 17239714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKAP9 is a genetic modifier of congenital long-QT syndrome type 1.
    de Villiers CP; van der Merwe L; Crotti L; Goosen A; George AL; Schwartz PJ; Brink PA; Moolman-Smook JC; Corfield VA
    Circ Cardiovasc Genet; 2014 Oct; 7(5):599-606. PubMed ID: 25087618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients.
    Fodstad H; Bendahhou S; Rougier JS; Laitinen-Forsblom PJ; Barhanin J; Abriel H; Schild L; Kontula K; Swan H
    Ann Med; 2006; 38(4):294-304. PubMed ID: 16754261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young.
    Tester DJ; Ackerman MJ
    J Am Coll Cardiol; 2007 Jan; 49(2):240-6. PubMed ID: 17222736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients.
    Jons C; O-Uchi J; Moss AJ; Reumann M; Rice JJ; Goldenberg I; Zareba W; Wilde AA; Shimizu W; Kanters JK; McNitt S; Hofman N; Robinson JL; Lopes CM
    Sci Transl Med; 2011 Mar; 3(76):76ra28. PubMed ID: 21451124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A novel KCNQ1 mutation in Chinese with congenital long QT syndrome].
    Liang L; Du ZD; Cai LL; Wu JX; Zheng T; Qi TX
    Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):724-7. PubMed ID: 14731347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a KCNQ1/KVLQT1 polymorphism in Asian families with LQT2: implications for genetic testing.
    Sharma D; Glatter KA; Timofeyev V; Tuteja D; Zhang Z; Rodriguez J; Tester DJ; Low R; Scheinman MM; Ackerman MJ; Chiamvimonvat N
    J Mol Cell Cardiol; 2004 Jul; 37(1):79-89. PubMed ID: 15242738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms in arrhythmia genes modify the risk of cardiac events and sudden death in long QT syndrome.
    Earle N; Yeo Han D; Pilbrow A; Crawford J; Smith W; Shelling AN; Cameron V; Love DR; Skinner JR
    Heart Rhythm; 2014 Jan; 11(1):76-82. PubMed ID: 24096169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing.
    Tester DJ; Benton AJ; Train L; Deal B; Baudhuin LM; Ackerman MJ
    Am J Cardiol; 2010 Oct; 106(8):1124-8. PubMed ID: 20920651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in Danish patients with long QT syndrome and the identification of a large founder family with p.F29L in KCNH2.
    Christiansen M; Hedley PL; Theilade J; Stoevring B; Leren TP; Eschen O; Sørensen KM; Tybjærg-Hansen A; Ousager LB; Pedersen LN; Frikke-Schmidt R; Aidt FH; Hansen MG; Hansen J; Bloch Thomsen PE; Toft E; Henriksen FL; Bundgaard H; Jensen HK; Kanters JK
    BMC Med Genet; 2014 Mar; 15():31. PubMed ID: 24606995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.